62
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer

, , , , &
Pages 1315-1323 | Published online: 18 Sep 2013

References

  • JemalASiegelRWardECancer statisticsCA Cancer J Clin200656210613016514137
  • BirchmeierCBirchmeierWGherardiEVande WoudeGFMet, metastasis, motility and moreNat Rev Mol Cell Biol200341291592514685170
  • ComoglioPMBoccaccioCScatter factors and invasive growthSemin Cancer Biol200111215316511322834
  • TrusolinoLComoglioPMScatter-factor and semaphorin receptors: cell signalling for invasive growthNat Rev200224289300
  • MaPCMaulikGChristensenJSalgiaRc-Met: structure, functions and potential for therapeutic inhibitionCancer Metastasis Rev200322430932512884908
  • CiprianiNAAbidoyeOOVokesESalgiaRMET as a target for treatment of chest tumorsLung Cancer200963216917918672314
  • IchimuraEMaeshimaANakajimaTNakamuraTExpression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significanceJpn J Cancer Res19968710106310698957065
  • MaPCJagadeeswaranRJagadeeshSFunctional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancerCancer Res20056541479148815735036
  • NakamuraYNikiTGotoAc-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysisCancer Sci20079871006101317459054
  • HanSWRomanJTargeting apoptotic signaling pathways in human lung cancerCurr Cancer Drug Targets201010656657420482489
  • GilmoreAPValentijnAJWangPActivation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptorJ Biol Chem200227731276432765012011069
  • RangerAMZhaJHaradaHBad-deficient mice develop diffuse large B cell lymphomaProc Natl Acad Sci U S A2003100169324932912876200
  • MaitiDBhattacharyyaABasuJLipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathwayJ Biol Chem2001276132933311020382
  • DownwardJHow BAD phosphorylation is good for survivalNat Cell Biol199912E33E3510559890
  • KurodaJTaniwakiMInvolvement of BH3-only proteins in hematologic malignanciesCrit Rev Oncol Hematol20097128910119022681
  • MaulikGMadhiwalaPBrooksSActivated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancerJ Cell Mol Med20026453955312611639
  • KijimaTMaulikGMaPCMadhiwalaPSchaeferESalgiaRFibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancerJ Cell Mol Med20037215716412927054
  • CooperCSParkMBlairDGMolecular cloning of a new transforming gene from a chemically transformed human cell lineNature1984311598129336590967
  • TsaoMSLiuNChenJRDifferential expression of MET/hepatocyte growth factor receptor in subtypes of non-small cell lung cancersLung Cancer19982011169699182
  • MasuyaDHuangCLiuDThe tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patientsBr J Cancer20049081555156215083185
  • ShibataTUryuSKokubuAGenetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic featuresClin Cancer Res200511176177618516144918
  • TsutaKKozuYMimaeTc-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomasJ Thorac Oncol20127233133922198430
  • BowersDCFanSWalterKAScatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathwaysCancer Res200060154277428310945642
  • JankowskiKKuciaMWysoczynskiMBoth hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapyCancer Res200363227926793514633723
  • De BaccoFLuraghiPMedicoEInduction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancerJ Natl Cancer Inst2011103864566121464397
  • LalBXiaSAbounaderRLaterraJTargeting the c-Met pathway potentiates glioblastoma responses to gamma-radiationClin Cancer Res200511124479448615958633
  • DziadziuszkoRWynesMWSinghSCorrelation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancerJ Thorac Oncol20127234034722237262
  • DattaSRDudekHTaoXAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machineryCell19979122312419346240
  • HuangYLiuDChenBLoss of Bad expression confers poor prognosis in non-small cell lung cancerMed Oncol20122931648165521918885
  • SinicropeFARegoRLFosterNRProapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancersClin Cancer Res200814134128413318593990
  • SeowHFYipWKLohHWIthninHPorPRohaizakMImmunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patientsPathol Oncol Res201116223924819882362
  • CartronPFLoussouarnDCamponeMMartinSAValletteFMPrognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiformeCell Death Dis20123e42123152057